{
    "2018-01-07": [
        [
            {
                "time": "",
                "original_text": "白云山回复上交所：‘两票制’致广州医药经营活动现金流净额为负",
                "features": {
                    "keywords": [
                        "白云山",
                        "两票制",
                        "广州医药",
                        "经营活动",
                        "现金流净额"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "白云山:收购广州医药30%股权,完善大商业版图",
                "features": {
                    "keywords": [
                        "白云山",
                        "收购",
                        "广州医药",
                        "股权",
                        "大商业版图"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}